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Abstract
Background: Congenital tuberculosis is a rare manifestation of tuberculosis. The diagnosis is often delayed,
especially in preterm neonates because of the non-specific clinical presentation and the lack of awareness of
maternal disease prior to pregnancy.
Case Presentation: We report a case of congenital tuberculosis in an infant born at 24 weeks of gestation to a
mother who presented with uncontrolled seizures during preterm labor. Maternal diagnosis was initially made by
placental pathology, and later confirmed by isolation of Mycobacterium tuberculosis in urine, gastric aspirates and
sputum. Full screening was performed on the newborn infant, and both mother and infant were successfully
treated for tuberculosis with a four drug regimen.
Conclusion: Pregnancy can exacerbate latent tuberculosis and women originating from endemic areas are
especially susceptible. The best way to prevent congenital tuberculosis is to have a high index of suspicion and
identify and treat tuberculosis in pregnant women.
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Background
Despite advances in therapeutics and diagnostic tech-
niques, tuberculosis (TB) continues to be a major infec-
tious cause of morbidity and mortality worldwide.
According to the World Health Organization, in 2015
there were 10.4 million new cases of TB worldwide of
which 3.5 million were women and 1 million children
[1]. TB continues to be amongst the top ten causes of
death worldwide [1]. Although, over 95% of TB deaths
occurs in low - and middle-income countries, the dis-
ease prevalence is increasing in developed countries due
to migration from endemic areas [2]. While the burden
of TB among pregnant women is equal to or greater
than in the general population, many cases remain un-
diagnosed because of low threshold of suspicion and
similarity of TB symptoms with physiological symptoms
of pregnancy [3]. Even in high risk countries of Asia and
Africa where severity of TB in pregnant women is con-
founded by HIV infection and malnutrition, screening
for TB in preterm or term neonates born to mothers
with confirmed or suspected TB infection remains in-
consistent at best [4].
The burden of TB in children is not well established
but is thought to account for 11% of all TB cases [2]. In
2014, 5% of the 1568 reported cases of TB in Canada
were in children 14 years or younger with 2.9% in in-
fants less than a year old [5]. Although data is limited,
the prevalence of vertically transmitted TB from infected
mothers to their off-springs can be as high as 16% [4].
Congenital TB can occur by hematogenous placental
transmission of the organism from the mother to the
fetus and also by ingestion of infected amniotic fluid or
by direct contact with the organism during birth [6]. Al-
though congenital TB is rare with about 350 cases re-
ported in the literature, the numbers may be much
higher as some cases could be missed as the diagnosis of
congenital TB is challenging with some cases not diag-
nosed and others not reported [7, 8]. Initially based on
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autopsy findings, the criteria for diagnosis of congenital
TB were revised in 1994 by Cantwell. These include the
presence of tuberculous lesions in the infant with at least
one of the following: lesions in the first week of life, a
primary hepatic complex or caseating granulomas, tu-
berculous infection of the placenta or endometrium and
exclusion of post-natal transmission of TB by screening
contacts [8–10].
Genital TB, a major cause of infertility in women from
endemic countries or belonging to high-risk ethnic
groups, is also a risk factor for congenital TB especially I
with increasing access to assisted reproductive technol-
ogy including in vitro fertilization (IVF) [11–14]. We re-
port a case of congenital TB in a 24-week gestation
infant whose mother had genital TB and who was con-
ceived by in vitro fertilization (IVF). To the best of our
knowledge, only five cases of congenital TB following
IVF have been described and of the 350 reported cases,
very few have reported adequate pathological evaluation
of the placenta.
Case Report
A 37-year-old South Asian woman with no significant
past medical history except for infertility and thalassemia
minor underwent IVF for the first time. Infertility
workup before IVF detected no abnormalities of the
uterus or tubal lesions but endometrial biopsies were
not performed. She had regular prenatal follow up, and
used folic acid and prenatal vitamins. With the exception
of intermittent vaginal bleeding noted since 10 weeks of
pregnancy, her pregnancy was uneventful until 20 weeks
of gestational age (GA) when she had spontaneous rup-
ture of membranes. Fetal ultrasound (US) showed severe
oligohydramnios. Repeat US at 23 weeks showed ab-
sence of the septum pellucidum and right talipes equino
varus in the fetus. At 24 weeks GA, the mother pre-
sented with generalized seizures, went into precipitous
labour delivering a male infant by spontaneous vaginal
delivery with a birthweight of 590 g and APGAR scores
of 4, 6, and 6 at 1, 5 and 10 min respectively.
Resuscitation of the infant in the case room included
intubation, intermittent positive pressure ventilation
with up to 100% oxygen and surfactant administration.
High Frequency Oscillatory Ventilation (HFOV) was
started in the case room due to the high oxygen require-
ments and absent chest movement.
The mother was admitted to the Intensive Care Unit
with continuous seizure activity for a diagnostic workup.
Diagnosis of TB was made by placental pathology on day
three post-delivery that showed necrotizing granulomatous
deciduitis and sub-chorionitis with acid-fast bacilli (AFB)
apparent on Ziehl-Neelsen staining (Fig. 1a, b). The find-
ings were suggestive of placental involvement from chronic
endometrial infection rather than recently acquired or
haematogenous infection. The parents denied any family
history of TB or contact with a known tuberculous patient.
Anti-tuberculosus treatment was started while awaiting
confirmation of the diagnosis. The diagnosis was con-
firmed by a positive Polymerase Chain Reaction (PCR) on
placental tissue for Mycobacterium Tuberculosis and cul-
ture of the organism from sputum and urine after 15 and
17 days of incubation respectively. Her chest X ray was
suggestive of military TB and CT scan of the chest con-
firmed the pulmonary involvement. An abdomen ultra-
sound was reported to be normal. Her brain magnetic
resonance imaging (MRI) showed multiple small ring-
enhancing cerebral and cerebellar lesions, consistent with
an atypical infection such as TB (Fig. 2).
Immediately after the diagnosis of maternal TB and
due to the complicated respiratory course of the infant
(HFOV in case room, repeated doses of surfactant, pres-
entation with Persistent Pulmonary Hypertension of
Newborn (PPHN) within 24 h of life that required nitric
oxide (iNO)), the infant was fully screened for TB.
Given the florid miliary and placental TB in the
mother and the infant’s critical condition, he was started
empirically on anti-tuberculous treatment on day 3 of
life. Mycobacterial culture of blood, cerebro-spinal fluid
(CSF), endotracheal aspirates, gastric aspirates, urine
and stool were, however, negative. Since confirming the
diagnosis of congenital TB is difficult and the associated
high mortality and morbidity, it was decided to continue
anti-tuberculous treatment. The infant was started on
isoniazid (10 mg/kg/d), rifampin (20 mg/kg/d), pyrazina-
mide (30 mg/kg/d), and ethambutol (20 mg/kg/d) for
2 months with a plan for isoniazid and rifampin for a
further 4 months. His course in NICU was complicated
by severe respiratory insufficiency, radiological evidence
of pulmonary interstitial emphysema and early signs of
chronic lung disease (CLD).
The baby remained on HFOV for 25 days and re-
quired iNO support for 29 days. A course of dexa-
methasone was required to facilitate extubation to
Continuous Positive Airway Pressure.
At 42 weeks of corrected GA the infant’s growth is
appropriate, he has CLD requiring oxygen via nasal
cannula and a brain MRI was reported to be normal.
His eye examination and liver function tests are nor-
mal. The mother continues her anti-TB treatment and
is doing well.
Discussion and conclusions
Our case report highlights the need to raise awareness
about the possibility of latent genital tuberculosis in an in-
fertile woman and initiating timely anti-tuberculous therapy
in newborns. Genital TB is a common cause of infertility in
women from areas where TB is prevalent [12]. However,
with increasing global migration, genital TB is being
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increasingly recognized in developed countries [2]. Al-
though congenital TB due to maternal genitourinary TB is
uncommon, the increasing availability of assisted repro-
ductive technologies, especially IVF, has the potential to in-
crease the prevalence of congenital TB [13, 15, 16].
Currently, IVF is one of the commonest treatment for in-
fertility, and the number of babies conceived through IVF
is increasing [14]. Presently, many women whose infertility
was caused by genital TB choose IVF as an option to con-
ceive [13, 16]. In developed countries, immigrants for en-
demic areas, such as the mother of our patient and HIV
infected mothers in resource limited countries would be at
high risk for TB. Screening for latent TB during pregnancy
can, however, be problematic. The tuberculin skin test can
be false positive in mothers who have received BCG vaccine
and be false negative in mothers with HIV. Some investiga-
tors do not recommend chest X-ray in pregnancy and the
AFB smear has a low sensitivity. AFB culture is time con-
suming and may not be easily available everywhere. The
interferon-gamma release assays (IGRA) test is recom-
mended by some investigators as the results are not af-
fected by BCG vaccination or HIV status [17]. Thus, a high
level of clinical suspicion has to be maintained in high risk
populations with a thorough assessment including a de-
tailed clinical history at the time of prenatal visits [3, 17].
Importantly, pregnant women with TB who are treated
appropriately do not have increased levels of maternal or
neonatal complications [17].
The infant in our case did not meet all of Cantwell’s
criteria as we were unable to isolate mycobacterium
tuberculosis from any of the biological samples. The
diagnosis of congenital TB can, however, be challenging.
Diagnostic tests for TB have extremely poor sensitivity
in newborns and some investigators suggest that the
Fig. 1 a Maternal surface of the placenta showing necrotizing granulomatous deciduitis. b Ziehl-Neelsen stain showing acid fast bacilli
Fig. 2 Maternal MRI showing small ring-enhancing lesions in both cerebral and cerebellar hemispheres
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diagnosis of congenital TB should be based on clinical
criteria [9, 10]. The tuberculin test is universally negative
in newborns and the IGRA is also usually negative as
the T lymphocytes in newborns do not have the capacity
to generate interferon-gamma in response to antigenic
stimulation [7, 9, 11]. The clinical symptoms associated
with congenital TB are non- specific and similar to those
in viral or other bacterial infections [2, 6, 9]. Further-
more, radiological chest findings may be non-specific [2,
6, 11]. Mycobacterial smears and PCR detection can be
negative in 30% of cases [7, 9]. However, a number of
clinical features placed this infant at extremely high risk
of having TB. The greatest risk of transmission to the
fetus is miliary or bacillemic TB in the mother at the
time of or just prior to delivery, like our case. Endomet-
rial and placental granulomas were present and AFB
were demonstrated in the placenta. The infant’s chest x-
ray also deteriorated rapidly although it was difficult to
ascertain whether this was due to prematurity or TB.
The neutrophil count was low (1.2 × 109/L) which has
been suggested as a bad prognostic sign in congenital
TB [11]. Importantly, mortality of untreated disease is
100% [9, 11]. Given these concerns, the infant was em-
pirically treated for TB. Amongst the five cases of con-
genital TB following IVF reported by Flibotte, the
organism could not be isolated from one infant [13].
Stuart et al. have reported a case after IVF where the or-
ganism was not detected in CSF, blood or gastric aspir-
ate by PCR or culture but was present in a lymph node
biopsy [15].
In summary, pregnancy can exacerbate latent TB in-
fection. Women from high TB prevalence areas are espe-
cially at risk and those with genital TB may transmit the
disease to the fetus. The diagnosis of congenital TB can
be difficult as diagnostic tests are insensitive and the
clinical signs and symptoms non-specific. The best way
to prevent congenital TB is to maintain a high index of
suspicion in women from high prevalence areas and to
identify and treat TB in pregnancy. Multicentre trials to
establish diagnostic tests including molecular tests such
as PCR, with better sensitivity and specificity for TB are
needed, especially in pregnancy and neonates.
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